Valuation: Norda ASA

Market Cap 513M 52.57M 45.99M 42.42M 39.17M 74.33M 5.01B 75.58M 507M 199M 2.47B 197M 193M 8.49B P/E 2023 *
-
P/E 2024 3.26x
Enterprise Value 264M 27.08M 23.69M 21.85M 20.18M 38.29M 2.58B 38.94M 261M 103M 1.27B 102M 99.47M 4.37B EV / Sales 2023
-1.24x
EV / Sales 2024 0.4x
Free-Float
6.26%
Yield 2023 *
-
Yield 2024 32.5%
Manager TitleAgeSince
Chief Executive Officer - 08/04/2013
Director TitleAgeSince
Chairman 54 31/01/2014
Director/Board Member 68 20/06/2013
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+3.37%-6.12% - - 45.42M
+0.58%+2.06%+2.92%+10.86% 50.73B
-2.22%-1.25%+385.40%+586.81% 39.73B
-0.54%+0.39%+25.57%-5.28% 34.69B
-1.36%+0.35%+17.88%+55.14% 33.21B
+1.21%-4.58%+3.00%+35.46% 26.76B
-1.81%-1.48% - - 16.8B
+0.51%-3.47%+63.97%+122.60% 15.37B
+0.23%-0.58%+13.76%+21.11% 13.78B
-0.62%-3.09%+10.29%-31.35% 12.85B
Average -0.07%-0.83%+65.35%+99.42% 27.1B
Weighted average by Cap. -0.48%-0.23%+80.69%+124.32%

Financials

2023 2024
Net sales 86.92M 8.9M 7.79M 7.18M 6.64M 12.59M 849M 12.8M 85.84M 33.71M 418M 33.43M 32.71M 1.44B 372M 38.1M 33.32M 30.74M 28.39M 53.86M 3.63B 54.77M 367M 144M 1.79B 143M 140M 6.15B
Net income 31.17M 3.19M 2.79M 2.58M 2.38M 4.52M 305M 4.59M 30.79M 12.09M 150M 11.99M 11.73M 516M 126M 12.9M 11.29M 10.41M 9.61M 18.24M 1.23B 18.55M 124M 48.84M 606M 48.45M 47.39M 2.08B
Net Debt -311M -31.89M -27.89M -25.73M -23.76M -45.08M -3.04B -45.84M -307M -121M -1.5B -120M -117M -5.15B -249M -25.49M -22.3M -20.57M -18.99M -36.04M -2.43B -36.65M -246M -96.5M -1.2B -95.71M -93.63M -4.12B
Logo Norda ASA
Norda ASA, formerly NorDiag ASA, is a Norway-based company active within the biotechnology sector. It develops, manufactures and markets automated solutions (instruments and tests) for sample preparation of bacterial and human DNA from difficult biological samples for use in the fields of infectious diseases, transplantation testing (HLA Typing) and others. The Company’s products include NorDiag Arrow (CE, IVD), which is a compact, automated solution for nucleic acid extractions, as well as NorDiag Bullet, 8 tip config, which is a fully automated sample preparation instrument for molecular diagnostics and can isolate from samples such as urine, swab, faces, sputum and blood. Its distribution products include Molzym GmbH and Co KG, as well as Hain Lifescience GmbH. Its customers are clinical laboratories, hospitals, research institutes, medical diagnostics and healthcare providers. It is operational through offices and laboratories in Norway, Sweden, Austria and the United States.
Employees
-